IHS Chemical Week

People & Business :: M&A

PolyTherics Acquires Warwick Effect Polymers

1:21 PM MST | January 26, 2012 | Deepti Ramesh

PolyTherics (London), a biotechnology company that applies precision chemistry to develop protein and peptide-based drugs, says it has acquired Warwick Effect Polymers (WEP; Coventry, U.K.), a provider of specialty biopolymers for the modification of biological products. Financial details were not disclosed. WEP has developed two proprietary biopolymer technologies, PolyPEG and GlycoPol. WEP has agreements with several global pharmaceutical and biotechnology companies for the evaluation of PolyPEG or GlycoPol and the company expects to announce licensing deals...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa